BR0006838A - Complexos de paroxetina, com ciclodextrinas ou derivados de ciclodextrinas - Google Patents

Complexos de paroxetina, com ciclodextrinas ou derivados de ciclodextrinas

Info

Publication number
BR0006838A
BR0006838A BR0006838-1A BR0006838A BR0006838A BR 0006838 A BR0006838 A BR 0006838A BR 0006838 A BR0006838 A BR 0006838A BR 0006838 A BR0006838 A BR 0006838A
Authority
BR
Brazil
Prior art keywords
paroxetine
complexes
cyclodextrins
cyclodextrin derivatives
cyclodextrin
Prior art date
Application number
BR0006838-1A
Other languages
English (en)
Inventor
Paolo Mascagni
Giuseppe Bottoni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI001459A external-priority patent/ITMI991459A1/it
Priority claimed from IT99MI002406 external-priority patent/IT1314232B1/it
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of BR0006838A publication Critical patent/BR0006838A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

<B>"COMPLEXOS DE PAROXETINA, COM CICLODEXTRINAS OU DERIVADOS DE CICLODEXTRINAS"<D>. A presente inveção se refere a complexos de paroxetina, na forma de uma base livre ou de um sal, com uma ciclodextrina ou um derivado de ciclodextrina, tendo uma razão molar entre paroxetina e ciclodextrina variando de 1:0,25 a 1:20, adequados para uso em composições farmacêuticas líquidas e sólidas, para administração oral ou parenteral.
BR0006838-1A 1999-07-01 2000-06-30 Complexos de paroxetina, com ciclodextrinas ou derivados de ciclodextrinas BR0006838A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI001459A ITMI991459A1 (it) 1999-07-01 1999-07-01 Complessi di sali di paroxetina con ciclodestrine
IT99MI002406 IT1314232B1 (it) 1999-11-17 1999-11-17 Complessi di paroxetina base con ciclodestrine o derivati delleciclodestrine.
PCT/EP2000/006121 WO2001002393A1 (en) 1999-07-01 2000-06-30 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives

Publications (1)

Publication Number Publication Date
BR0006838A true BR0006838A (pt) 2001-08-07

Family

ID=26331667

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0006838-1A BR0006838A (pt) 1999-07-01 2000-06-30 Complexos de paroxetina, com ciclodextrinas ou derivados de ciclodextrinas

Country Status (13)

Country Link
US (1) US6984632B1 (pt)
EP (1) EP1109806B8 (pt)
JP (1) JP2003503493A (pt)
KR (1) KR100759159B1 (pt)
AT (1) ATE248165T1 (pt)
AU (1) AU5535900A (pt)
BR (1) BR0006838A (pt)
CA (1) CA2341984A1 (pt)
DE (1) DE60004768T2 (pt)
DK (1) DK1109806T3 (pt)
ES (1) ES2206254T3 (pt)
PT (1) PT1109806E (pt)
WO (1) WO2001002393A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
CA2672971C (en) * 2007-01-23 2014-03-11 Pharmagra Labs, Inc. Stabilized sulforaphane

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
CA2206592A1 (en) 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US5672612A (en) 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2001503406A (ja) * 1996-10-28 2001-03-13 ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ 医薬組成物
JPH10167958A (ja) * 1996-12-09 1998-06-23 Sankyo Co Ltd ロキソプロフェンナトリウム類を含有する口腔内速溶性製剤及びその製造方法
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物
AP9901604A0 (en) 1997-01-15 1999-09-30 Smithkline Beecham Plc Paroxetine compositions.
ZA981558B (en) * 1997-02-27 1998-08-27 Novo Nordisk As Inclusion complexes in aqueous solution
HUP9700632A3 (en) * 1997-03-24 1999-10-28 Cyclolab Ciklodextrin Kutato F Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
EP0994872B9 (en) * 1997-06-10 2001-12-05 Synthon B.V. 4-phenylpiperidine compounds
GB9724544D0 (en) 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
EP1102764A1 (en) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Paroxetine salts

Also Published As

Publication number Publication date
EP1109806B8 (en) 2003-10-29
KR100759159B1 (ko) 2007-09-14
CA2341984A1 (en) 2001-01-11
ES2206254T3 (es) 2004-05-16
KR20010072880A (ko) 2001-07-31
EP1109806B1 (en) 2003-08-27
US6984632B1 (en) 2006-01-10
JP2003503493A (ja) 2003-01-28
PT1109806E (pt) 2004-02-27
ATE248165T1 (de) 2003-09-15
WO2001002393A1 (en) 2001-01-11
DK1109806T3 (da) 2003-12-22
AU5535900A (en) 2001-01-22
DE60004768D1 (de) 2003-10-02
DE60004768T2 (de) 2004-07-08
EP1109806A1 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
DE69623449D1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
MY121999A (en) Inclusion complexes of aryl-heterocyclic salts
CA2074186A1 (en) Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
HUP0101564A2 (hu) Epotilon készítmények
RU94028890A (ru) Композиции производных циклодекстрина, композиции, содержащие лекарство и производные циклодекстринов
NO20050629L (no) Inclusion complexes of butylphthalid with cyclodextrin or its derivatives, a process for their preparation and the use thereof
TJ275B (en) Derivatives of cyclodextrins exhibiting enhenced aqueous solubility and the use thereof
TR199903191T2 (xx) Vorikonazol i�eren ila� form�lasyonlar�.
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell&#39;iperossaluria.
ATE198834T1 (de) Konjugate bestehend aus polysaccharid und protein
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
PT992509E (pt) Novos derivados macrolidos
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
BR0006838A (pt) Complexos de paroxetina, com ciclodextrinas ou derivados de ciclodextrinas
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
AU2408602A (en) Indole derivatives and use thereof in medicines
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
BR9914125A (pt) Composições farmacêuticas baseadas em alfa-ciclodextrina para administração oral de análogos lh-rh
AU1584800A (en) Immuno-active, anti-cancer and pharmacologically active polysaccharide compoundsand pharmaceutical compositions containing the polysaccharide compounds
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
FR2789078B3 (fr) Derives d&#39;acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10(VIII), 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.